Published on in Vol 7, No 3 (2018): March

Preprints (earlier versions) of this paper are available at https://preprints.jmir.org/preprint/8655, first published .
Treatment with Creatine Monohydrate in Spinal and Bulbar Muscular Atrophy: Protocol for a Randomized, Double-Blind, Placebo-Controlled Trial

Treatment with Creatine Monohydrate in Spinal and Bulbar Muscular Atrophy: Protocol for a Randomized, Double-Blind, Placebo-Controlled Trial

Treatment with Creatine Monohydrate in Spinal and Bulbar Muscular Atrophy: Protocol for a Randomized, Double-Blind, Placebo-Controlled Trial

Yasuhiro Hijikata   1 , MD, PhD ;   Masahisa Katsuno   1 * , MD, PhD ;   Keisuke Suzuki   1, 2 , MD, PhD ;   Atsushi Hashizume   1 , MD, PhD ;   Amane Araki   1 , MD, PhD ;   Shinichiro Yamada   1 , MD, PhD ;   Tomonori Inagaki   1 , MD ;   Daisuke Ito   1 , MD ;   Akihiro Hirakawa   3 , PhD ;   Fumie Kinoshita   3 , MSc ;   Masahiko Gosho   4 , PhD ;   Gen Sobue   1, 5 * , MD, PhD

1 Department of Neurology, Nagoya University Graduate School of Medicine, Nagoya, Japan

2 Innovation Center for Clinical Research, National Center for Geriatnics and Gerontology, Obu, Japan

3 Biostatistics Section, Center for Advanced Medicine and Clinical Research, Nagoya University Graduate School of Medicine, Nagoya, Japan

4 Department of Clinical Trial and Clinical Epidemiology, Faculty of Medicine, University of Tsukuba, Tsukuba, Japan

5 Research Division of Dementia and Neurodegenerative Disease, Nagoya University Graduate School of Medicine, Nagoya, Japan

*these authors contributed equally